TYROBP and neoplasm: In OS, the under-expression of SPI1-TYROBP-FCER1G network in tumor cells or microenvironmental endothelial cells/myeloid cells can potentially attenuate the immune infiltration and T cell activation, leading to the metastasis/poorer prognosis of OS (Fig. 8C).